Financhill
Buy
66

BEAM Quote, Financials, Valuation and Earnings

Last price:
$28.20
Seasonality move :
-26.75%
Day range:
$28.62 - $29.93
52-week range:
$13.53 - $36.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
49.35x
P/B ratio:
3.08x
Volume:
1.5M
Avg. volume:
1.9M
1-year change:
13.05%
Market cap:
$3B
Revenue:
$63.5M
EPS (TTM):
-$4.43

Earnings Data

Next earnings date for BEAM
Feb 24
2026
Most recent earnings per share
-$1.10
Missed by $0.09
(Nov 4/2025)
Consensus Estimate
-$1.01
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BEAM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $13.7M -- -- -$1.16 --
02/24/2026 Q4 $13.2M -- -- -$1.11 --
11/04/2025 Q3 $12.7M $9.7M -$1.10 -$1.01 -$0.09
08/05/2025 Q2 $13.3M $8.5M -$1.00 -$1.09 $0.09
05/06/2025 Q1 $14.7M $7.5M -$1.24 -$1.17 -$0.07
02/25/2025 Q4 $16.5M $30.1M -$1.09 -$1.22 $0.12
11/05/2024 Q3 $14.1M $14.3M -$1.17 -$1.18 $0.01
08/06/2024 Q2 $13M $11.8M -$1.11 -$1.12 $0.01
05/07/2024 Q1 $14.7M $7.4M -$1.21 -$1.39 $0.18
02/27/2024 Q4 $33.7M $316.2M $1.73 -$0.71 $2.44
11/08/2023 Q3 -- $17.2M -$1.22 -- --
08/08/2023 Q2 -- $20.1M -$1.08 -- --
05/10/2023 Q1 -- $24.2M -$1.33 -- --
02/28/2023 Q4 -- $20M -$0.54 -- --
11/07/2022 Q3 -- $15.8M -$1.56 -- --
08/09/2022 Q2 -- $16.7M -$1.02 -- --
05/09/2022 Q1 -- $8.4M -$1.01 -- --
02/28/2022 Q4 -- $51.1M -$0.95 -- --
11/08/2021 Q3 -- $763K -$0.42 -- --
08/10/2021 Q2 -- $6K -$1.23 -- --
05/11/2021 Q1 -- $6K -$3.35 -- --
03/30/2021 Q4 -- $6K -$1.69 -- --
11/10/2020 Q3 -- $6K -$0.69 -- --
08/12/2020 Q2 -- $6K -$0.69 -- --
05/12/2020 Q1 -- $6K -$1.03 -- --
03/30/2020 Q4 -- $6K -$0.61 -- --
09/30/2019 Q3 -- $6K -$0.43 -- --
06/30/2019 Q2 -- $6K -$0.41 -- --
03/31/2019 Q1 -- -- -$0.32 -- --
12/31/2018 Q4 -- -- -$0.51 -- --
09/30/2018 Q3 -- -- -$1.37 -- --

Beam Therapeutics, Inc. Earnings Questions

  • How Much did Beam Therapeutics, Inc. Generate in Revenue Last Quarter?

    Beam Therapeutics, Inc. reported $9.7M worth of top line sales in its most recent quarter.

  • Did Beam Therapeutics, Inc. Beat Earnings Last Quarter?

    Beam Therapeutics, Inc. announced earnings per share of -$1.10 which represents a miss of analyst forecast a -$1.01 per share.

  • Is Beam Therapeutics, Inc. Profitable?

    Beam Therapeutics, Inc. reported $4.1M that represents $0.04 per share over the last quarter.

  • What is the Analyst Consensus for Beam Therapeutics, Inc. EPS Next Year?

    Beam Therapeutics, Inc.'s earnings are forecast to decrease from -$4.58 per share to -$4.22 per share next year representing a decrease of -0.12%.

  • When is Beam Therapeutics, Inc.'s Earnings Date?

    Beam Therapeutics, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.7T
P/E Ratio: 66x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Alerts

Buy
67
PFSI alert for Jan 30

PennyMac Financial Services, Inc. [PFSI] is down 31.3% over the past day.

Buy
78
GDXU alert for Jan 30

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 34.24% over the past day.

Sell
46
CVCO alert for Jan 30

Cavco Industries, Inc. [CVCO] is down 16.6% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock